Amarin Future Growth
Future criteria checks 1/6
Amarin is forecast to grow earnings and revenue by 47.3% and 11.3% per annum respectively while EPS is expected to grow by 46.9% per annum.
Key information
47.3%
Earnings growth rate
46.9%
EPS growth rate
Biotechs earnings growth | 30.2% |
Revenue growth rate | 11.3% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 09 May 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 271 | -16 | N/A | 49 | 3 |
12/31/2025 | 215 | -65 | N/A | 12 | 4 |
12/31/2024 | 202 | -70 | 21 | -11 | 3 |
3/31/2024 | 277 | -53 | 1 | 1 | N/A |
12/31/2023 | 307 | -59 | 6 | 7 | N/A |
9/30/2023 | 322 | -52 | 8 | 9 | N/A |
6/30/2023 | 346 | -38 | -17 | -16 | N/A |
3/31/2023 | 361 | -91 | -89 | -88 | N/A |
12/31/2022 | 369 | -106 | -181 | -180 | N/A |
9/30/2022 | 423 | -92 | -210 | -210 | N/A |
6/30/2022 | 476 | -100 | -196 | -196 | N/A |
3/31/2022 | 536 | -22 | -147 | -147 | N/A |
12/31/2021 | 583 | 8 | -67 | -67 | N/A |
9/30/2021 | 606 | -2 | -77 | -77 | N/A |
6/30/2021 | 620 | 4 | -61 | -61 | N/A |
3/31/2021 | 601 | 1 | -45 | -45 | N/A |
12/31/2020 | 614 | -18 | -22 | -22 | N/A |
9/30/2020 | 590 | -16 | 7 | 8 | N/A |
6/30/2020 | 546 | -13 | 17 | 19 | N/A |
3/31/2020 | 511 | -19 | 30 | 33 | N/A |
12/31/2019 | 430 | -23 | -12 | -9 | N/A |
9/30/2019 | 364 | -63 | -35 | -33 | N/A |
6/30/2019 | 307 | -84 | -83 | -83 | N/A |
3/31/2019 | 259 | -117 | -123 | -123 | N/A |
12/31/2018 | 229 | -116 | -95 | -95 | N/A |
9/30/2018 | 206 | -105 | -65 | -65 | N/A |
6/30/2018 | 198 | -92 | -43 | -43 | N/A |
3/31/2018 | 190 | -71 | -29 | -29 | N/A |
12/31/2017 | 181 | -68 | N/A | -33 | N/A |
9/30/2017 | 166 | -73 | N/A | -50 | N/A |
6/30/2017 | 151 | -78 | N/A | -62 | N/A |
3/31/2017 | 139 | -78 | N/A | -61 | N/A |
12/31/2016 | 130 | -86 | N/A | -72 | N/A |
9/30/2016 | 118 | -81 | N/A | -76 | N/A |
6/30/2016 | 107 | -97 | N/A | -80 | N/A |
3/31/2016 | 91 | -147 | N/A | -96 | N/A |
12/31/2015 | 82 | -149 | N/A | -84 | N/A |
9/30/2015 | 72 | -147 | N/A | -74 | N/A |
6/30/2015 | 64 | -141 | N/A | -72 | N/A |
3/31/2015 | 59 | -62 | N/A | -57 | N/A |
12/31/2014 | 54 | -56 | N/A | -75 | N/A |
9/30/2014 | 48 | -52 | N/A | -92 | N/A |
6/30/2014 | 42 | -75 | N/A | -117 | N/A |
3/31/2014 | 35 | -130 | N/A | -158 | N/A |
12/31/2013 | 26 | -166 | N/A | -190 | N/A |
9/30/2013 | 16 | -161 | N/A | -201 | N/A |
6/30/2013 | 8 | -139 | N/A | -196 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: EH3A is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: EH3A is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: EH3A is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: EH3A's revenue (11.3% per year) is forecast to grow faster than the German market (5.2% per year).
High Growth Revenue: EH3A's revenue (11.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if EH3A's Return on Equity is forecast to be high in 3 years time